Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical (LFCR) Restructuring Costs: 2020-2025

Historic Restructuring Costs for Lifecore Biomedical (LFCR) over the last 3 years, with Feb 2025 value amounting to -$115,000.

  • Lifecore Biomedical's Restructuring Costs fell 114.92% to -$115,000 in Q1 2025 from the same period last year, while for Feb 2025 it was $1.6 million, marking a year-over-year increase of 67.49%. This contributed to the annual value of -$1.7 million for FY2025, which is 205.50% down from last year.
  • Lifecore Biomedical's Restructuring Costs amounted to -$115,000 in Q1 2025, which was down 115.58% from $738,000 recorded in Q2 2024.
  • In the past 5 years, Lifecore Biomedical's Restructuring Costs ranged from a high of $5.3 million in Q1 2022 and a low of -$115,000 during Q1 2025.
  • In the last 3 years, Lifecore Biomedical's Restructuring Costs had a median value of $157,000 in 2023 and averaged $587,857.
  • Per our database at Business Quant, Lifecore Biomedical's Restructuring Costs surged by 9,125.00% in 2024 and then tumbled by 114.92% in 2025.
  • Over the past 5 years, Lifecore Biomedical's Restructuring Costs (Quarterly) stood at $627,000 in 2021, then fell by 10.21% to $563,000 in 2022, then slumped by 72.11% to $157,000 in 2023, then soared by 9,125.00% to $738,000 in 2024, then slumped by 114.92% to -$115,000 in 2025.
  • Its last three reported values are -$115,000 in Q1 2025, $738,000 for Q2 2024, and $771,000 during Q1 2024.